Clinical Trial Update: Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating pembrolizumab plus lenvatinib and chemotherapy as first-line treatment for extensive-stage small cell lung cancer; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• LENVIMA (lenvatinib)

Snippet

Sponsor: Fundación GECP | Conditions: Small Cell Lung Cancer Extensive Stage | Phase 2 | Status: RECRUITING